Talya Increases Production Capacity Tenfold with $6 Million Investment

Talya Bitkisel, which has been operating in the dietary supplements and aromatherapy products sector for approximately 23 years, implemented a USD 6 million factory investment as of 2025. With this strategic investment, the company aims to increase its monthly production capacity in dietary supplements from 1 million units to 10 million units as of 2026.

At the new production facility established on a total area of 10,000 square meters, production lines for dietary supplements, vitamins and aromatherapy products will be progressively commissioned starting from the beginning of 2026. Upon completion of the investment process, a comprehensive transformation in Talya's production infrastructure is anticipated.

DEEPENING EXPORT AMBITIONS
Talya Bitkisel, which exports to more than 40 countries, aims to further strengthen its presence in international markets alongside the ongoing investment process. One of the important turning points in the company's growth journey was the strategic partnership realized with OYAK in 2023. This partnership strengthened Talya's corporate and financial structure while establishing a solid foundation for long-term scaling objectives.

AS THE GLOBAL MARKET ADVANCES TO USD 300 BILLION, TALYA FOCUSES ON SCIENCE AND SAFETY
Talya Bitkisel Founder M. Halis Ertaş, noting that the global dietary supplements and vitamin market currently stands at approximately USD 200 billion and is expected to approach USD 300 billion over the next 5-6 years, made the following assessment regarding the sector's future:

"Turkey, with its botanical diversity, production infrastructure and geographical location, is among the countries that can benefit from this growth. In the dietary supplements and aromatherapy sector, we are now speaking not only of rapid growth; but of science-based, traceable and safety-driven development. As Talya increases its production capacity, our focus is not only on volume; but on quality, traceability and scientific references."

50% GROWTH TARGET IN DOMESTIC AND EXPORT MARKETS BY 2026
Ertaş, emphasizing that the American market plays a critical role in Talya's export and scaling strategy, continued as follows:

"We are transferring our approximately 23 years of production experience into a larger-scale and sustainable structure alongside the ongoing investment process. As of 2026, we anticipate an average growth of 50% in both the domestic market and exports. Our objective is to establish a permanent and reliable brand structure in international markets that approaches dietary supplements, vitamins and aromatherapy within the same scientific framework."